PRY is important, but far from the decider. At an additional 22% it still doesn't get PHG access to VEI's cash flows, which it needs to control its own ballooning debts.
PHG appears to have underestimated the power of other stakeholders, such as the doctor partners whom can still pull the company apart, particularly at the thought some American will come here to teach them how to run an ophthalmology business in Australia.
Literally quite stupid.
VEI Price at posting:
75.0¢ Sentiment: Buy Disclosure: Not Held